171 related articles for article (PubMed ID: 33914102)
1. Pattern of relapse in pediatric localized extremity rhabdomyosarcomas correlated with locoregional therapies administered.
Welmant J; Helfre S; Carton M; Bolle S; Minard-Colin V; Corradini N; Pannier S; Rome A; Mansuy L; Vérité C; Castex MP; Kerr C; Defachelles AS; Bernier V; Orbach D
Strahlenther Onkol; 2021 Aug; 197(8):690-699. PubMed ID: 33914102
[TBL] [Abstract][Full Text] [Related]
2. Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study.
Terwisscha van Scheltinga SEJ; Wijnen MHWA; Martelli H; Rogers T; Mandeville H; Gaze MN; McHugh K; Corradini N; Orbach D; Jenney M; Kelsey A; Chisholm J; Gallego S; Glosli H; Ferrari A; Zanetti I; De Salvo GL; Minard-Colin V; Bisogno G; van Noesel MM; Merks HHM
Cancer Med; 2020 Oct; 9(20):7580-7589. PubMed ID: 32869534
[TBL] [Abstract][Full Text] [Related]
3. In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: Analysis of the EpSSG RMS 2005 study.
Terwisscha van Scheltinga CEJ; Wijnen MHWA; Martelli H; Guerin F; Rogers T; Craigie RJ; Burrieza GG; Dall'Igna P; De Corti F; Smeulders N; van Rijn RR; Fajardo RD; Mandeville HC; Zanetti I; Coppadoro B; Minard-Colin V; Jenney M; Bisogno G; van Noesel MM; van der Steeg AFW; Merks JHM
Eur J Surg Oncol; 2022 Jul; 48(7):1536-1542. PubMed ID: 35307252
[TBL] [Abstract][Full Text] [Related]
4. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
Lobeck I; Dupree P; Karns R; Rodeberg D; von Allmen D; Dasgupta R
J Pediatr Surg; 2017 Apr; 52(4):614-617. PubMed ID: 27642084
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma.
Mandell L; Ghavimi F; LaQuaglia M; Exelby P
Med Pediatr Oncol; 1990; 18(6):466-71. PubMed ID: 2233517
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
[TBL] [Abstract][Full Text] [Related]
7. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
[TBL] [Abstract][Full Text] [Related]
8. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G;
Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665
[TBL] [Abstract][Full Text] [Related]
9. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
Dantonello TM; Int-Veen C; Winkler P; Leuschner I; Schuck A; Schmidt BF; Lochbuehler H; Kirsch S; Hallmen E; Veit-Friedrich I; Bielack SS; Niggli F; Kazanowska B; Ladenstein R; Wiebe T; Klingebiel T; Treuner J; Koscielniak E
J Clin Oncol; 2008 Jan; 26(3):406-13. PubMed ID: 18202417
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
11. Value of the Sentinel Node Procedure in Pediatric Extremity Rhabdomyosarcoma: A Systematic Review and Retrospective Cohort Study.
Jeremiasse B; van der Steeg AFW; Fiocco M; Hobbelink MGG; Merks JHM; Godzinski J; Shulkin BL; Wijnen MHWA; Terwisscha van Scheltinga CEJ
Ann Surg Oncol; 2021 Dec; 28(13):9048-9059. PubMed ID: 34057567
[TBL] [Abstract][Full Text] [Related]
12. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
[TBL] [Abstract][Full Text] [Related]
13. Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.
La TH; Wolden SL; Rodeberg DA; Hawkins DS; Brown KL; Anderson JR; Donaldson SS
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1151-7. PubMed ID: 20542386
[TBL] [Abstract][Full Text] [Related]
14. Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 study.
Guérin F; Rogers T; Minard-Colin V; Gaze MN; Terwisscha S; Van Noesel M; De Corti F; Guillén Burrieza G; De Salvo GL; Kelsey A; Orbach D; Ferrari A; Bergeron C; Bisogno G; Martelli H
Pediatr Blood Cancer; 2019 Jul; 66(7):e27725. PubMed ID: 30920113
[TBL] [Abstract][Full Text] [Related]
15. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
16. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
[TBL] [Abstract][Full Text] [Related]
17. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
[TBL] [Abstract][Full Text] [Related]
18. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
20. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
